KFA
SHPH icon

Kelleher Financial Advisors’s Shuttle Pharmaceuticals SHPH Stock Holding History

Kelleher Financial Advisors’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390 Buy
120
+60
+100% +$393 ﹤0.01% 844
2026
Q1 		$407 Buy
+60
New +$813 ﹤0.01% 670

Other funds holding SHPH

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Kelleher Financial Advisors's SHPH Position: Q2 2026 in Review

Kelleher Financial Advisors increased its Shuttle Pharmaceuticals (SHPH) stake by 100% in Q2 2026, buying an estimated $393 and bringing the position to 120 shares worth $390. The position accounts for ﹤0.01% of the portfolio, ranked #844.

Kelleher Financial Advisors first reported a position in SHPH in Q1 2026 and has held it in 2 quarters since. The position peaked at $407 in Q1 2026. 5 funds tracked by Wall St. Rank hold SHPH as of Q2 2026.

  • Kelleher Financial Advisors held 120 shares of Shuttle Pharmaceuticals worth $390 as of Q2 2026.
  • Kelleher Financial Advisors bought 60 Shuttle Pharmaceuticals shares in Q2 2026, an estimated $393.
  • Shuttle Pharmaceuticals made up ﹤0.01% of Kelleher Financial Advisors's portfolio in Q2 2026, its #844 holding.
  • Kelleher Financial Advisors first reported a position in Shuttle Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Kelleher Financial Advisors's Shuttle Pharmaceuticals position peaked at $407 in Q1 2026.
  • 5 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q2 2026.

Based on Kelleher Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.